The expression and correlation between the transcription factor FOXP1 and estrogen receptors in epithelial ovarian cancer

Biochimie

Volumn 109, Issue , 2015, Pages 42-48

  Hu, Zhenhua ^a,b   Zhu, Liancheng ^a   Tan, Mingzi ^a   Cai, Mingbo ^a   Deng, Lu ^a   Yu, Guannan ^a   Liu, Dawo ^a   Liu, Juanjuan ^a   Lin, Bei ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b ZHENGZHOU UNIVERSITY   (China)

Author keywords

Estrogen receptor; FOXP1; Interaction; Ovarian cancer

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MESSENGER RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXP1; UNCLASSIFIED DRUG; FORKHEAD TRANSCRIPTION FACTOR; FOXP1 PROTEIN, HUMAN; PROTEIN BINDING; REPRESSOR PROTEIN;

ADULT; ARTICLE; BENIGN TUMOR; CANCER TISSUE; CONTROLLED STUDY; CYTOPLASM; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEOPLASM; OVARY TUMOR; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BLOTTING, WESTERN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PROTEIN BINDING; REPRESSOR PROTEINS; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84919775214     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2014.12.001     Document Type: Article

References (27)

1. F. Moduqno, R. Laskey, A.L. Smith, C.L. Andersen, P. Haluska, S. Oesterreich, Hormone response in ovarian cancer: time to reconsider as a clinical target? Endoc Relat. Cancer 19 (2012) 255-279.
2. A. Morani, M. Warner, J.A. Gustafsson, Biological functions and clinical implications of oestrogen receptors alfa and beta in epithelial tissues, J. Intern. Med. 264 (2008) 128-142.
3. P.A. Thompson, I. Ljuslinder, S. Tsavachidis, A. Brewster, A. Sahin, H. Hedman, R. Henriksson, M.L. Bondy, B.S. Melin, Loss of LRIG1 locus increases risk early and late relapse of stage I/II breast Cancer, Cancer Res. 74 (2014) 2928-2935.
4. M.I. Toma, M. Grosser, A. Herr, D.E. Aust, A. Meye, C. Hoefling, S. Fuessel, D. Wuttig, M.P. Wirth, G.B. Baretton, Loss of heterozygosity and copy number abnormality in clear cell renal cell carcinoma discovered by high-density affymetrix 10K single nucleotide polymorphism mapping array, Neoplasia 10 (2008) 634-642.
5. B. Wang, J. Weidenfeld, M.M. Lu, S. Maika, W.A. Kuziel, E.E. Morrisey, P.W. Tucker, Foxp1 regulates cardiac outflow tract, endocardial cushion morphogenesis and myocyte proliferation and maturation, Development 131 (2004) 4477-4487.
6. K. Takayama, K. Horie-Inoue, K. Ikeda, T. Urano, K. Murakami, Y. Hayashizaki, Y. Ouchi, S. Inoue, FOXP1 is an androgen-responsive transcription factor that negatively regulates androgen receptor signaling in prostate cancer cells, Biochem. Biophys. Res. Commun. 374 (2008) 388-393.
7. A.H. Banham, N. Beasley, E. Campo, P.L. Fernandez, C. Fidler, K. Gatter, M. Jones, D.Y. Mason, J.E. Prime, P. Trougouboff, K. Wood, J.L. Cordell, The FOXP1 winged helix transcription factor is a novel candidate tumor suppressor gene on chromosome 3p, Cancer Res. 61 (2001) 8820-8829.
8. M. Rayoo, M. Yan, E.A. Takano, G.J. Bates, P.J. Brown, A.H. Banham, S.B. Fox, Expression of the forkhead box transcription factor FOXP1 is associated with oestrogen receptor alpha, oestrogen receptor beta and improved survival in familial breast cancers, J. Clin. Pathol. 62 (2009) 896-902.
9. G.J. Bates, S.B. Fox, C. Han, R. Launchbury, R.D. Leek, A.L. Harris, A.H. Banham, Expression of the forkhead transcription factor FOXP1 is associated with that of estrogen receptor-beta in primary invasive breast carcinomas, Breast Cancer Res. Treat. 111 (2008) 453-459.
10. T. Shigekawa, N. Ijichi, K. Ikeda, K. Horie-Inoue, C. Shimizu, S. Saji, K. Aogi, H. Tsuda, A. Osaki, T. Saeki, S. Inoue, FOXP1, an eatrogen-inducible transcription factor, modulates cell proliferation in breast cancer cells and 5-year recurrence-free survival of patients with tamoxifen-treated breast cancer, Horm. Cancer 2 (2011) 286-297.
11. M.A. Augello, T.E. Hickey, K.E. Knudsen, FOXA1: master of steroid receptor function in cancer, EMBO J. 30 (2011) 3885-3894.
12. M. Buh Gasparic, T. Tengs, J.L. La Paz, A. Holst-Jensen, M. Pla, T. Esteve, J. Zel, K. Gruden, Comparison of nine different real-time PCR chemistries for qualitative and quantitative applications in GMO detection, Anal. Bioanal. Chem. 396 (2010) 2023-2029.
13. E.C. Jensen, The basics of western blotting, Anat. Rec. Hob. 295 (2012) 369-371.
14. T.R. Mattiske, M.H. Tan, J. Gecz, C. Shoubridge, Challenges of "sticky" co-immunoprecipitation: polyalanine tract protein-protein interactions, Methods Mol. Biol. 1017 (2013) 121-133.
15. D. Kabelik, A.M. Kelly, J.L. Goodson, Dopaminergic regulation of mate competition aggression and aromatase-Fos colocalization in vasotocin neurons, Neuropharmacology 58 (2010) 117-125.
16. L. P, J. A, K. B, Identification of ten exon deleted ERbeta mRNAs in human ovary, breast, uterus and bone tissues: alternate splicing pattern of estrogen receptor beta mRNA is distinct from that of estrogen receptor alpha, FEBS Lett. 516 (2002) 133-138.
17. S. Cunat, P. Hofmann, P. Pujol, Estrogens and epithelial ovarian cancer, Gynecol. Oncol. 94 (2004) 25-32.
18. B. Huang, Y. Omoto, H. Iwase, H. Yamashita, T. Toyama, R.C. Coombes, A. Filipovic, M. Warner, J.A. Gustafsson, Differential expression of estrogen receptor alpha, beta1, and beta2 in lobular and ductal breast cancer, Proc. Natl. Acad. Sci. U. S. A. 111 (2014) 1933-1938.
19. R.M. Savoy, P.M. Ghosh, The changing roles of steroid nuclear receptors with prostate cancer progression, Endocrine-related cancer 20 (2013) C9-C11.
20. J.M. Siegfried, L.P. Stabile, Estrongenic steroid hormones in lung cancer, Seminars Oncol. 41 (2014) 5-16.
21. G.F. Zannoni, G. Monterossi, I. De Stefano, A. Gargini, M.G. Salerno, I. Farulla, D. Travaglia, V.G. Vellone, G. Scambia, D. Gallo, The expression ratios of estrogen receptor alpha (ERalpha) to estrogen receptor beta1 (ERbeta1) and ERalpha to ERbeta2 identify poor clinical outcome in endometrioid endometrial cancer, Hum. pathol. 44 (2013) 1047-1054.
22. R.K. Jain, R.J. Mehta, H. Nakshatri, M.T. Idrees, S.S. Badve, High-level expression of forkhead-box protein A1 in metastatic prostate cancer, Histopathology 58 (2011) 766-772.
23. I. Wolf, S. Bose, E.A. Williamson, C.W. Miller, B.Y. Karlan, H.P. Koeffler, FOXA1: growth inhibitor and a favorable prognostic factor in human breast cancer, Int. J. Cancer. J. Int. du Cancer 120 (2007) 1013-1022.
24. N. Ijichi, T. Shigekawa, K. Ikeda, K. Horie-Inoue, C. Shimizu, S. Saji, K. Aogi, H. Tsuda, A. Osaki, T. Saeki, S. Inoue, Association of double-positive FOXA1 and FOXP1 immunoreactivities with favorable prognosis of tamoxifen-treated breast cancer patients, Horm. Cancer 3 (2012) 147-159.
25. G.M. Bernardo, R.A. Keri, FOXA1: a transcription factor with parallel functions in development and cancer, Biosci. Rep. 32 (2012) 113-130.
26. F. Suzuki, J. Akahira, I. Miura, T. Suzuki, K. Ito, S. Hayashi, H. Sasano, N. Yaegashi, Loss of estrogen receptor beta isoform expression and its correlation with aberrant DNA methylation of the 5′-untranslated region in human epithelial ovarian carcinoma, Cancer Sci. 99 (2008) 2365-2372.
27. A.H. Banham, J. Boddy, R. Launchbury, C. Han, H. Turley, P.R. Malone, A.L. Harris, S.B. Fox, Expression of the forkhead transcription factor FOXP1 is associated both with hypoxia inducible factors (HIFs) and the androgen receptor in prostate cancer but is not directly regulated by androgens or hypoxia, Prostate 67 (2007) 1091-1098.